“Compared to normal plasma, hemophilia plasma delays clot formation and reduces stability in tissue factor-triggered assays, and products that enhance hemostasis improve these characteristics.” All ...

Blood clots form in response to signals from the lungs of cancer patients—not from other organ sites, as previously thought—according to a preclinical study by Weill Cornell Medicine, Memorial Sloan ...

In a recent study under review in the Journal of Hematology & Oncology journal and currently available on the Research Square* preprint server, researchers investigated the presence of severe acute ...

Are astronauts more likely to develop blood clots during space missions due to zero gravity? That's the question NASA is trying to answer with help from UNC School of Medicine's Stephan Moll, MD, ...

Using a murine model of venous thrombosis, scientists demonstrated that exposure to red light significantly reduces clot formation. Mice exposed to red light prior to inferior vena cava (IVC) ligation ...

Blood clots form in response to signals from the lungs of cancer patients—not from other organ sites, as previously thought—according to a preclinical study by Weill Cornell Medicine, Memorial Sloan ...

A study from a COVID-19 cohort reveals an additional link between the immune system and blood clots, which could improve the treatment of critical illnesses. Blood clots are thought to occur in as ...

East Carolina University’s Dr. Nathan Hudson is leading research to better understand how blood clots form, what impacts degradation of clots and new ways to attack them to help improve the diagnosis ...

Blood clots form in response to signals from the lungs of cancer patients -- not from other organ sites, as previously thought -- according to a preclinical study. Clots are the second-leading cause ...

Blood clots form in response to signals from the lungs of cancer patients—not from other organ sites, as previously thought—according to a preclinical study by Weill Cornell Medicine, Memorial Sloan ...